DrugInfoSys

Ziprasidone

Drug #1930

Ziprasidone is a new antipsycotic drug with combined dopamine and serotinin receptor antagonist activity.

Primary Characteristics

Ziprasidone is also known as Ziprasidone HCL Monohydrate.

Molecular Weight: 412.94 · Non-proprietary name: Ziprasidone.

Molecular structure of Ziprasidone

Pharmacokinetics

Distribution: Ziprasidone has a plasma protein binding is >99%.

Elimination: it is metabolised via hepatic, plasma half-life is 2-5 hours, renal excretion is 20% as metabolites,66% in feces.

Advertisement

Indications

Ziprasidone is primarily indicated in conditions like Schizophrenia.

Ziprasidone is also indicated for secondary conditions like Depression, Mania, Tourette's syndrome.

Contraindications

Ziprasidone is contraindicated in conditions like Cardiac arrhythmia, Hypersensitivity reactions, QTc prolongation.

Dosage

Ziprasidone's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
25 mg25 mgEvery 12hIMPatient sholud switch therapy as soon as possible.
90 mg90 mgEvery 12hORALGiven every 2 days.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

6 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Ziprasidone in overdosage may give rise to further complications which include Fever , QT prolongation, Muscle twitching , Rashes.

Ziprasidone produces potentially life-threatening effects which include Seizures . Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Ziprasidone are Sedation , Constipation, Somnolence, Dyspepsia.

Ziprasidone is known to cause more or less tolerable side effects which are usually transient. These include Agitation , Anxiety, Blood dyscrasias, Cholestatic Jaundice , Confusion, Dizziness, Extra pyramidal symptoms, GI disturbance, Headache, Hepatitis, Hyperglycemia, Hyperlipidemia, Hyperprolactinemia, Hypertension , Nausea, Obesity, Orthostatic hypotension, Seizures, Sexual dysfunction, Sneezing, Somnolence , Tardive dyskinesia.

Warnings / Precautions

Ziprasidone should be avoided in combination with other drugs that are known to prolong QTc interval.Avoid use of alcohol.Avoid activities involving high temperature. It should not be used in patients with a history of seizures and cerebrovascular disease.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Storage Conditions

Ziprasidone should be stored .

Drug Classification

  1. 1.24.1Drugs used in psychotic disorders

Manufacturers